INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)

CUSIP: 45773H409

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
66,777,963
Total 13F shares
298,900
Share change
+298,883
Total reported value
$152,940
Price per share
$0.51
Number of holders
7
Value change
+$152,930
Number of buys
6

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q4 2023

As of 31 Dec 2023, INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 298,900 shares. The largest 7 holders included PRICE T ROWE ASSOCIATES INC /MD/, TUDOR INVESTMENT CORP ET AL, Farther Finance Advisors, LLC, EverSource Wealth Advisors, LLC, Cornerstone Planning Group LLC, Advisory Services Network, LLC, and Financial Gravity Asset Management, Inc.. This page lists 7 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.